Origin Agritech Holds Annual R&D and Operations Management Conference, Establishes 2026 Strategic Priorities
BEIJING, Dec. 22, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, announced the results of its Annual Research & Development and Operations Management Conference held at the Company's Beijing headquarters from November 22-24, 2025. The three-day strategic planning session brought together senior management, department heads, subsidiary leadership, and leading agricultural...
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA), a clinical-stage oncology company focused on developing innovative therapies for cancer, today announced that it has regained full compliance with all applicable listing standards of Nasdaq. On December 18, 2025, the...
AI Platform to Combat Muscle Loss and Preserve Metabolic Vitality for GLP-1 Users
Livelively USA combines AI insights with Eastern wellness principles to support healthier long-term weight management behaviors. NEW YORK, Dec. 22, 2025 /PRNewswire/ -- Weight-loss medications are reshaping global healthcare, with the anti-obesity drug market projected to approach $100 billion by 2030, according to Goldman Sachs. As millions begin GLP-1 therapy, interest is growing around how to maintain strength, vitality,...
Yii Partners with Japan’s ANDS Corporation: Building Skin Resilience through Pharmaceutical-Grade Science
HONG KONG, Dec. 22, 2025 /PRNewswire/ -- Japanese skincare brand Yii is collaborating with ANDS Corporation (hereinafter "ANDS"), an affiliate of Rohto Pharmaceutical Co., Ltd., to explore the niche skincare market with pharmaceutical-grade scientific excellence. The collaboration combines over 60 years of ANDS's formulation expertise with Yii's Eastern philosophy of "Nourish effortless beauty," delivering proven efficacy and high safety...
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for imlunestrant in metastatic or recurrent breast cancer previously treated with endocrine therapy
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunestrant TOKYO, Dec. 22, 2025 /PRNewswire/ -- Guardant Health Japan Corp. today announced that the Ministry of Health, Labour and Welfare (MHLW) has approved Guardant360® CDx on 23 October 2025 as a...
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
The secondary analysis of the PACE trial highlights the value of counting Circulating Tumor Cells (CTCs) in the blood to help guide treatment escalation or de-escalation in patients with hormone receptor-positive (HR+), HER2-negative (HER2-) metastatic breast cancer whose disease progressed after treatment with aromatase inhibitors plus CDK4/6 inhibitors. CTC count is a...
OK Biotech Recognized at International Innovation Awards (IIA) 2025 for OTC Hearing Aid Innovation
SHANGHAI, Dec. 22, 2025 /PRNewswire/ -- OK Biotech Co., Ltd. has been honoured at the International Innovation Awards (IIA) 2025, organized by Enterprise Asia, for its development of the OKB OTC Hearing Aid, a device designed to improve comfort and sound clarity for adults with hearing loss. The OKB OTC Hearing Aid was created from personal experience, with the...
The 8th Hainan International Health Industry Expo opens in Sanya
HAIKOU, China, Dec. 22, 2025 /PRNewswire/ -- A report from Hainan International Media Center: On December 20, 2025, the 8th Hainan International Health Industry Expo opened in Sanya. Coinciding with the crucial juncture of the Hainan Free Trade Port's island-wide special customs operations, this Expo serves as both a platform for Hainan to showcase achievements in the development of...
Wong To Yick Unveils Revitalised Official Website
Launching a New No.1 Brand Chapter with Ambassador Joey Yung Enhanced Authenticity Guidance & Usage Education for Elevated Consumer Confidence HONG KONG, Dec. 22, 2025 /PRNewswire/ -- Wong To Yick, the iconic Hong Kong medicated balm brand trusted for over half a century, proudly unveils its newly upgraded official website, marking...
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation to: TLX591-CDx (Illuccix® in approved jurisdictions, 68Ga-PSMA-11): Positive data from Phase 3 study in Chinese patients provides the basis for near-term NDA submission in China. TLX101-CDx...
